浩欧博(688656)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688656 浩欧博

已收盘 11-05 15:00:01

{"stockData":{"symbol":"688656","market":"SH","secType":"STK","nameCN":"浩欧博","latestPrice":66.46,"timestamp":1730790001000,"preClose":55.38,"halted":0,"volume":819880,"delay":0,"floatShares":63058300,"shares":63058300,"eps":0.5592,"marketStatus":"已收盘","marketStatusCode":5,"change":11.08,"latestTime":"11-05 15:00:01","open":66.46,"high":66.46,"low":66.46,"amount":54489200,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":66.46,"bidSize":63404,"shortable":0,"etf":0,"ttmEps":0.5592,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730856600000},"adr":0,"adjPreClose":55.38,"symbolType":"stock_kcb","openAndCloseTimeList":[[1730770200000,1730777400000],[1730782800000,1730790000000]],"highLimit":60.92,"lowLimit":49.84,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":63058328,"pbRate":5.2,"roa":"--","roe":"3.27%","epsLYR":0.75,"marketValue":4191000000,"floatMarketCap":4191000000,"peRate":118.848357,"changeRate":0.2001,"turnoverRate":0.013,"status":0,"afterMarket":{"amount":0,"volume":0,"close":66.46,"buyVolume":33408,"sellVolume":0,"time":1730792039464,"indexStatus":"已收盘 11-05 15:30:00","preClose":55.38}},"requestUrl":"/m/hq/s/688656","defaultTab":"news","newsList":[{"id":"2481200855","title":"浩欧博最新公告：公司近期日常经营情况正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2481200855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481200855?lang=zh_cn&edition=full","pubTime":"2024-11-05 18:11","pubTimestamp":1730801467,"startTime":"0","endTime":"0","summary":"浩欧博公告，公司股票交易连续2个交易日内（2024年11月4日、2024年11月5日）日收盘价格涨幅偏离值累计达到30%，属于股票交易异常波动。同时，公司股票交易连续4个交易日内（2024年10月31日至2024年11月5日）日收盘价格涨幅偏离值累计达到100%，属于股票交易严重异常波动。公司近期日常经营情况正常，未发生重大变化。市场环境或行业政策未发生重大调整，生产成本和销售等情况未出现大幅波动、内部生产经营秩序正常。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500031040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"gpt_icon":0},{"id":"2481252524","title":"11月5日浩欧博（688656）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2481252524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481252524?lang=zh_cn&edition=full","pubTime":"2024-11-05 17:16","pubTimestamp":1730798188,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2024年11月5日公布的交易公开信息显示，浩欧博因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券，有价格涨跌幅限制的连续3个交易日内收盘价格涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2024年11月5日收盘，浩欧博报收于66.46元，上涨20.01%，已连续涨停4天，换手率1.3%，成交量8199.0手，成交额5448.92万元。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500030129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"gpt_icon":0},{"id":"2481752976","title":"股票暴涨60%，IVD企业发布紧急公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2481752976","media":"MedWorld器械世界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481752976?lang=zh_cn&edition=full","pubTime":"2024-11-05 16:26","pubTimestamp":1730795217,"startTime":"0","endTime":"0","summary":"来源：企业公告10月30日，IVD上市公司浩欧博披露控制权拟发生变更的公告，正大集团旗下的港股上市公司中国生物制药拟采用“协议转让+部分要约”的方式进行收购，获得公司控制权。中国生物制药公布收购浩欧博控制权公告发布后，引发市场关注。这是浩欧博自10月31日复牌以来，斩获的第三个涨停。因股票交易异常波动，浩欧博紧急发公告说明。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105163444aba14eef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105163444aba14eef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688656"],"gpt_icon":0},{"id":"2481919105","title":"浩欧博触及涨停 创近2年新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2481919105","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481919105?lang=zh_cn&edition=full","pubTime":"2024-11-05 09:30","pubTimestamp":1730770201,"startTime":"0","endTime":"0","summary":"11月05日，浩欧博股价大幅上涨，截至09点30分，浩欧博触及涨停，报66.46元/股，创近2年新高，突破60元整数关口，成交927万元，换手率0.22%。资金动向截止发稿，浩欧博获得主力净流入578万元，其中超大单流入1121万元，大单流出542万元。此外，浩欧博11月04日上榜龙虎榜。最新财报显示，今年三季报，浩欧博实现营业收入3.07亿元，同比增长2.29%，净利润为2,656.30万元，同比减少31.24%，基本每股收益为0.42元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105093219ab9fd26c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105093219ab9fd26c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688656"],"gpt_icon":0},{"id":"2480937288","title":"浩欧博连续2日累计涨幅偏离值达30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480937288","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480937288?lang=zh_cn&edition=full","pubTime":"2024-11-04 17:17","pubTimestamp":1730711855,"startTime":"0","endTime":"0","summary":"公告指出，公司股票在2024年10月31日和11月1日连续两个交易日内日收盘价格涨幅偏离值累计达到30%，属于股票交易异常波动。自2024年10月31日至2024年11月4日，公司股票连续3个交易日涨停，短期内涨幅较大，提醒投资者注意投资风险。同时，辉煌润康和双润正安将向公司全体股东发出要约收购1557万股股份，占剔除回购专用账户后股份总数的25%。文章来源：财中社浩欧博连续2日累计涨幅偏离值达30%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104173948a21493a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104173948a21493a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688656"],"gpt_icon":0},{"id":"2480719933","title":"11月4日浩欧博（688656）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2480719933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480719933?lang=zh_cn&edition=full","pubTime":"2024-11-04 17:13","pubTimestamp":1730711623,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2024年11月4日公布的交易公开信息显示，浩欧博因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2024年11月4日收盘，浩欧博报收于55.38元，上涨20.0%，已连续涨停3天，换手率0.4%，成交量2544.0手，成交额1409.12万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400023385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"gpt_icon":0},{"id":"2480619379","title":"浩欧博最新公告：股票交易异常波动 连续3个交易日涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2480619379","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480619379?lang=zh_cn&edition=full","pubTime":"2024-11-04 16:59","pubTimestamp":1730710796,"startTime":"0","endTime":"0","summary":"浩欧博公告，公司股票交易于2024年10月31日、2024年11月1日连续两个交易日内日收盘价格涨幅偏离值累计达到30%，属于股票交易异常波动。截至本公告披露日，公司生产经营情况正常，内外部经营环境未发生重大变化。本次股份转让完成后，公司控股股东将由海瑞祥天变更为辉煌润康，公司实际控制人将由JOHN LI、WEIJUN LI、陈涛变更为中国生物制药有限公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400021927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"gpt_icon":0},{"id":"2480376340","title":"龙虎榜|浩欧博上涨20.00%，华鑫证券西安解放路席位买入548.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480376340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480376340?lang=zh_cn&edition=full","pubTime":"2024-11-04 16:40","pubTimestamp":1730709613,"startTime":"0","endTime":"0","summary":"11月4日，浩欧博上涨20.00%，龙虎榜数据显示，当日上榜营业部全天成交2144.17万元，占当日总成交金额比例为152.16%。其中，买入金额为1409.12万元，卖出金额为735.05万元，合计净买入674.06万元。此外华鑫证券西安解放路、国金证券杭州利一路营业部分别买入548.82万元、547.61万元；华福证券泉州丰泽街、财通证券杭州文二西路营业部分别卖出435.79万元、110.76万元；值得注意的是，这也是浩欧博在30日内第3次上榜龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104164019a21453f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104164019a21453f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688656","161027"],"gpt_icon":0},{"id":"2480031087","title":"浩欧博涨停创2年新高 百亿元级私募机构密集调研医疗器械行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2480031087","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480031087?lang=zh_cn&edition=full","pubTime":"2024-11-04 09:30","pubTimestamp":1730683801,"startTime":"0","endTime":"0","summary":"11月04日，浩欧博股价大幅上涨，截至09点30分，浩欧博触及涨停，报55.38元/股，创近2年新高，突破50元整数关口，成交725万元，换手率0.21%。消息解读10月份，共有49家百亿元级私募机构对A股上市公司进行调研，覆盖69个申万二级行业中的252家公司，合计调研次数达623次。其中，医疗器械行业的上市公司被百亿元级私募机构调研次数遥遥领先，达66次。此外，浩欧博11月01日上榜龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093308ab9c385e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093308ab9c385e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688656","159883"],"gpt_icon":0},{"id":"2480821038","title":"IVD企业暴涨40%，紧急公告！","url":"https://stock-news.laohu8.com/highlight/detail?id=2480821038","media":"IVD资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480821038?lang=zh_cn&edition=full","pubTime":"2024-11-02 21:33","pubTimestamp":1730554408,"startTime":"0","endTime":"0","summary":"浩欧博连续两天涨停。因股票交易异常波动，浩欧博紧急发公告说明。经公司自查并向控股股东、实际控制人核实，截至本公告披露日，除公司已披露信息外，公司、公司控股股东海瑞祥天及实际控制人 JOHN LI、WEIJUN LI、陈涛（不存在应披露而未披露的重大信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102213411ab98ba30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102213411ab98ba30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688656","BK0239"],"gpt_icon":0},{"id":"2480085370","title":"浩欧博拟6.3亿元“卖身”中国生物制药 前三季度归母净利润同比下降三成","url":"https://stock-news.laohu8.com/highlight/detail?id=2480085370","media":"中国网财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480085370?lang=zh_cn&edition=full","pubTime":"2024-11-01 18:12","pubTimestamp":1730455920,"startTime":"0","endTime":"0","summary":"按照双方约定，浩欧博2024年、2025年、2026年实现的归母净利润应分别不低于4970万元、5218万元、5479万元，扣非归母净利润分别不低于4547万元、4774万元、5013万元。今年前三季度浩欧博实现营业收入3.07亿元，同比增长2%；归母净利润2656万元，同比下降三成，距离业绩承诺中的年度4970万元归母净利润目标还差2314万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101181517a2083e36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101181517a2083e36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688656"],"gpt_icon":0},{"id":"2480074632","title":"11月1日浩欧博（688656）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2480074632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480074632?lang=zh_cn&edition=full","pubTime":"2024-11-01 17:14","pubTimestamp":1730452462,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2024年11月1日公布的交易公开信息显示，浩欧博因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券，有价格涨跌幅限制的连续3个交易日内收盘价格涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2024年11月1日收盘，浩欧博报收于46.15元，上涨19.99%，已连续涨停2天，换手率0.18%，成交量1124.0手，成交额518.93万元。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100032600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"gpt_icon":0},{"id":"2480079688","title":"龙虎榜|浩欧博上涨19.99%，东海证券常州劳动西路席位买入461.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480079688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480079688?lang=zh_cn&edition=full","pubTime":"2024-11-01 16:30","pubTimestamp":1730449842,"startTime":"0","endTime":"0","summary":"11月1日，浩欧博上涨19.99%，龙虎榜数据显示，当日上榜营业部全天成交798.66万元，占当日总成交金额比例为153.91%。其中，买入金额为518.93万元，卖出金额为279.73万元，合计净买入239.20万元。此外东海证券常州劳动西路、广发证券郑州航海东路营业部分别买入461.11万元、57.82万元；第一创业证券北京西城分公司、国海证券深圳宝安裕安路营业部分别卖出103.96万元、56.75万元；值得注意的是，这也是浩欧博在30日内第2次上榜龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101163050a207ab6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101163050a207ab6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688656","161027"],"gpt_icon":0},{"id":"2480025090","title":"“H吃A”、“并购六条”后首例！泰国首富看上一家业绩下滑企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2480025090","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480025090?lang=zh_cn&edition=full","pubTime":"2024-11-01 13:39","pubTimestamp":1730439540,"startTime":"0","endTime":"0","summary":"值得注意的是，这是收购是首例港股上市公司收购A股公司的案例，也是“并购六条”发布后，首单科创板公司作为收购标的的案例。本次交易完成后，浩欧博将成为中国生物制药在A股证券市场控股的第一家上市子公司。“国内过敏原检测第一股”浩欧博于2021年1月在科创板上市，主要业务为自免检测和过敏检测。浩欧博在三季报中指出，业绩下滑主要系股份支付费用、新药注册临床费用及新大楼固定资产折旧增加；理财收益、其他收益减少导致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101135524a206b85d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101135524a206b85d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","688656","BK1191","BK1515","01177","BK1521"],"gpt_icon":0},{"id":"2480127970","title":"“并购六条”后首单科创板公司被收购案出炉 中国生物制药拟入主浩欧博","url":"https://stock-news.laohu8.com/highlight/detail?id=2480127970","media":"市场投研资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480127970?lang=zh_cn&edition=full","pubTime":"2024-11-01 10:01","pubTimestamp":1730426460,"startTime":"0","endTime":"0","summary":"科创企业牵手产业龙头公告显示，中国生物制药拟采取“协议转让+部分要约”方式收购浩欧博约55%股权。中国生物制药拟由其境内全资子公司辉煌润康以协议转让方式受让浩欧博的控股股东海瑞祥天29.99%股份，转让价约为6.3亿元。本次权益变动完成后，浩欧博的控股股东将变更为辉煌润康，公司实际控制人将变更为中国生物制药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-01/doc-incupkpn2242737.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-01/doc-incupkpn2242737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK1515","BK1521","01177","BK0239","688656","159982","BK1589"],"gpt_icon":0},{"id":"2479303720","title":"医药巨头并购潮再起，中国生物制药收购科创板企业浩欧博","url":"https://stock-news.laohu8.com/highlight/detail?id=2479303720","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479303720?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:11","pubTimestamp":1730387460,"startTime":"0","endTime":"0","summary":"生物医药领域的并购重组仍在持续。10月30日晚间，科创板上市公司浩欧博披露了公司控制权拟发生变更的公告，港股上市企业中国生物制药亦于同日披露此股权收购事项。根据双方约定，中国生物制药拟采用“协议转让+部分要约”的方式对浩欧博进行收购，收购价为每股33.74元、总价格6.3亿元。收购完成后，通过全资子公司辉煌润康和控股子公司双润正安，中国生物将持有浩欧博55%股权，取得控制权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-10-31/doc-incunpiu3780301.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-10-31/doc-incunpiu3780301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688656","159938","159982","BK1161","01177","BK1521","BK1589","BK0239","BK1191","BK1574","09939","BK1515"],"gpt_icon":0},{"id":"2479038367","title":"史上首例H收A，“泰国首富”再获一家上市公司！","url":"https://stock-news.laohu8.com/highlight/detail?id=2479038367","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479038367?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:39","pubTimestamp":1730381976,"startTime":"0","endTime":"0","summary":"正大集团医药板块再添一子","market":"us","thumbnail":"https://img2.gelonghui.com/ac691-dbb4760e-26a3-4c54-85e3-3871a4c24d43.png?guru_height=1000&guru_width=1600","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/ac691-dbb4760e-26a3-4c54-85e3-3871a4c24d43.png?guru_height=1000&guru_width=1600"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1251396","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["688656","BK1515","BK1521","01177","BK1589","BK0239","BK1191"],"gpt_icon":0},{"id":"2479044217","title":"“并购六条”后 中国生物制药操刀科创板首单“H吃A”跨界体外诊断业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2479044217","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479044217?lang=zh_cn&edition=full","pubTime":"2024-10-31 19:04","pubTimestamp":1730372670,"startTime":"0","endTime":"0","summary":"预计浩欧博合并进入集团报表后将对中国生物制药财务表现产生积极贡献。中国生物制药方面表示，收购完成后，公司将提名浩欧博的董事长、监事会主席，以及所有高管。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031190511ab8acaea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031190511ab8acaea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1521","01177","688656","BK1589"],"gpt_icon":0},{"id":"2479702945","title":"重磅收购！中国生物制药二次回A","url":"https://stock-news.laohu8.com/highlight/detail?id=2479702945","media":"新康界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479702945?lang=zh_cn&edition=full","pubTime":"2024-10-31 18:39","pubTimestamp":1730371190,"startTime":"0","endTime":"0","summary":"方面提到，收购完成后，浩欧博将成为中国生物制药在A股市场的第一家上市附属公司，浩欧博的诊断业务也将与其形成业务协同。如今仅过去一年半，中国生物制药终于得以借助并购重组政策的东风，再度借壳回A。而比起被收购的浩欧博，中国生物制药10月31日当天的股价表现相对平淡，低开高走，但盘中最高涨幅不超过3%。中国生物制药方面表示，预计浩欧博合并进入集团报表后,将对公司财务表现产生积极贡献。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031191856a20166ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031191856a20166ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["399300","688656","01177","159982","BK0239"],"gpt_icon":0},{"id":"2479577512","title":"浩欧博创60日新高，国元证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479577512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479577512?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:19","pubTimestamp":1730362762,"startTime":"0","endTime":"0","summary":"今日浩欧博创60日新高，收盘报38.46元。2024年9月2日，国元证券研究员马云涛发布了对浩欧博的研报《2024半年报点评：业绩平稳增长，脱敏药新业务值得期待》，该研报对浩欧博给出“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为国元证券的马云涛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100031270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728","688656"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-01-13","address":"江苏省苏州市吴中区苏州工业园区星湖街218号生物纳米园C6栋101","stockEarnings":[{"period":"1week","weight":0.7279},{"period":"1month","weight":0.933},{"period":"3month","weight":1.4701},{"period":"6month","weight":1.1725},{"period":"1year","weight":0.4413},{"period":"ytd","weight":0.6212}],"companyName":"江苏浩欧博生物医药股份有限公司","boardCode":"AI0027","perCapita":"24058股","boardName":"医药制造业","registeredCapital":"6305万元","compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0079},{"period":"3month","weight":0.1545},{"period":"6month","weight":0.0581},{"period":"1year","weight":0.0922},{"period":"ytd","weight":0.1127}],"survey":"　　江苏浩欧博生物医药股份有限公司是专业从事体外诊断试剂的研发、生产和销售的高新技术企业。公司的产品主要用于血液中相关抗体检测，有过敏和自免两大产品系列。浩欧博已进入以北京协和、上海仁济、中国医大二院、华西二院等为代表的多家旗帜性医院。与金域医学、迈瑞医疗等国内龙头企业建立战略合作关系。","serverTime":1730816545583,"listedPrice":35.26,"stockholders":"2621人(较上一季度减少4.79%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"浩欧博(688656)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供浩欧博(688656)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"浩欧博,688656,浩欧博股票,浩欧博股票老虎,浩欧博股票老虎国际,浩欧博行情,浩欧博股票行情,浩欧博股价,浩欧博股市,浩欧博股票价格,浩欧博股票交易,浩欧博股票购买,浩欧博股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"浩欧博(688656)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供浩欧博(688656)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}